Effect of phenprocoumon on monitoring of lepirudin, argatroban, melagatran and unfractionated heparin with the PiCT method

被引:21
作者
Fenyvesi, T [1 ]
Jörg, I [1 ]
Harenberg, J [1 ]
机构
[1] Univ Hosp, Dept Med 4, D-68167 Mannheim, Germany
关键词
prothrombinase-induced clotting time; thrombin inhibitors; phenprocoumon; additive effects;
D O I
10.1159/000070423
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prothrombinase-induced clotting time (PiCT) is a clotting-time test for heparins and direct thrombin inhibitors to reduce drawbacks of aPTT. Effects of the direct thrombin inhibitors lepirudin, argatroban, melagatran and of unfractionated heparin (UFH) were investigated in normal and oral anticoagulant plasma samples. Lepirudin showed potentiating interferences with phenprocoumon effects. Melagatran, argatroban and UFH delivered distinct linear additive effects in both plasma sample groups. PiCT ratio reduces differences between both groups with UFH, and argatroban inhibitor-receptor-binding mode plays a role in interaction patterns.
引用
收藏
页码:174 / 179
页数:6
相关论文
共 29 条
[1]   PROSPECTIVE STUDY OF VALUE OF MONITORING HEPARIN TREATMENT WITH ACTIVATED PARTIAL THROMBOPLASTIN TIME [J].
BASU, D ;
CADE, J ;
GALLUS, A ;
HIRSH, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (07) :324-+
[2]  
BAUMANN P, 1991, HAEMOSTASIS, V21, P329
[3]  
Calatzis A, 2000, HAEMOSTASIS, V30, P172
[4]  
Elg M, 1997, THROMB HAEMOSTASIS, V78, P1286
[5]  
ERIKSSON UG, 2001, THROMB HAEMOST S, P86
[6]   The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteers [J].
Faaij, RA ;
van Griensven, JMT ;
Schoemaker, RC ;
Goggin, T ;
Guenzi, A ;
Kroon, JM ;
Burggraaf, J ;
Cohen, AF .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (01) :25-29
[7]  
FENTON JW, 1991, HAEMOSTASIS, V21, P27
[8]  
FRANCIS CW, 2001, THROMB HAEMOST S, P86
[9]   Recombinant hirudin (Lepirndin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia -: A prospective study [J].
Greinacher, A ;
Völpel, H ;
Janssens, U ;
Hach-Wunderle, V ;
Kemkes-Matthes, B ;
Eichler, P ;
Mueller-Velten, HG ;
Pötzsch, B .
CIRCULATION, 1999, 99 (01) :73-80
[10]   Anticoagulation in patients with heparin-induced thrombocytopenia type II [J].
Harenberg, J ;
Huhle, G ;
Piazolo, L ;
Wang, LCU ;
Heene, DL .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (02) :189-196